Jasleen Hospital

Nagpur, Maharashtra 44012

0 studies enrolling now · 6 studies all time

What they study most

Lupus Erythematosus, Systemic, Lupus Nephritis, Systemic Lupus Erythematosus

Studies at this site

• A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) — Stopped early
• Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study — Stopped early
• Study of VIB7734 for the Treatment of Moderate to Severely Active SLE — Completed
• A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) — Completed